[如何在2024年管理动脉高血压以优化心脏和脏保护]
1Néphrologue Consultant CHU Liège et Professeur ordinaire honoraire ULiège, Belgique.
Revue medicale de Liege
|June 13, 2024
概括
动脉高血压管理的2023年新指南强调精确的血压测量和整体的患者护理. 一般医生在治疗中发挥着关键作用,旨在在三个月内使血压正常并降低心血管风险.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 一般的做法一般的做法
背景情况:
- 动脉高血压是一个重要的心血管风险因素,需要有效的管理策略.
- 2023年指南更新了对高血压诊断和治疗的建议.
- 精确的血压测量对于有效的高血压管理至关重要.
研究的目的:
- 总结2023年动脉高血压管理指南中的关键建议.
- 为了强调精确的血压测量技术的重要性.
- 突出全科医生在管理高血压患者中的作用.
主要方法:
- 对最新发布的动脉高血压管理指南的审查 (2023年夏季).
- 强调在咨询室使用带有手套的自动示波器件来测量血液压力.
- 专注于患者教育,药物遵守,以及解决治疗惯性问题.
主要成果:
- 该指南重申了准确,自动化血压测量的重要性.
- 考虑所有患者风险因素的整体方法至关重要.
- 一般医生是诊断,治疗和监测的核心.
结论:
- 有效的高血压管理需要准确的测量,患者教育和整体护理.
- 目标是在三个月内使血压正常化,并最大限度地降低心血管风险.
- 预防医学策略是长期患者结果的关键.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Hypertension and Regulation of Blood Pressure
2.0K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.0K
Antihypertensive Drugs: Direct Renin Inhibitors
567
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
567
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
611
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
611
Heart Failure Drugs: Diuretics
363
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
363
Antihypertensive Drugs: Angiotensin II Receptor Blockers
706
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
706


